Skip to content
★ Sign in to follow
株式

株式会社アンビションDXホールディングス Stock: price and insider trades · Japan

JP·Mcap JP¥13.5BHealth Care

株式会社アンビションDXホールディングス: what insiders have been doing

株式会社アンビションDXホールディングス is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). In the past year (26 October 2025 to 26 October 2026), 5 filings came from 1 insider.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

For context, the typical company on the same exchange (median of 3,205 companies) published 3 filings over the same period, against 5 filings here.

There has been no open-market purchase by an insider of 株式会社アンビションDXホールディングス for at least a year. Filings reach the EDINET (Japan FSA) feed a median of 7 days after the trade. Until a filing is published, the market cannot know about the trade.

This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.

Insider Decl.
12
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,381 of 26,897 companies
49.5
score / 100
Value
54
Quality
46
FCF yld-41%
Earn yld17%
EV/EBITDA9.2x
ROE23%
Gross mgn20%
Net mgn4.5%
Debt/EBITDA6.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended June 2025 · cache

JP¥1,813
Analyst consensus
·
Income statement
RevenueJP¥52.4B
Gross profitJP¥10.6B20% margin
EBITDAJP¥4.2B8% margin
Net incomeJP¥2.4B3.8% margin
Valuation
PER (trailing)6.7x
P/Book1.4x
Beta0.23
Balance sheet & cash
Market capJP¥13.5B
Total debtJP¥25.2B
Free Cash Flow-JP¥5.5B
Debt / Equity307%
Profitability & ownership
ROE22.6%
ROA6.1%
% insiders59.5%
% institutions3.1%
Last declaration on 7 April 2026
Declarations12 total
  • ●
    Large shareholderExecutives
    6EDINET
    13.3% of flowShareXTKSEDINET:S100XWZ7
  • ●
    OfficerExecutives
    12EDINET
    13.1% of flowShareXTKSEDINET:S100XHLP
  • ●
    Large shareholderExecutives
    6EDINET
    14.8% of flowShareXTKSEDINET:S100XGUK
  • ●
    Large shareholderExecutives
    7EDINET
    19.6% of flowShareXTKSEDINET:S100X98Y
  • ●
    Large shareholderExecutives
    7EDINET
    19.0% of flowShareXTKSEDINET:S100WXZ9
  • ●
    Large shareholderExecutives
    5EDINET
    1.9% of flowShareXTKSEDINET:S100WRHV
  • ●
    Large shareholderExecutives
    5EDINET
    1.9% of flowShareXTKSEDINET:S100WELR
  • ●
    OfficerExecutives
    12EDINET
    5.2% of flowShareXTKSEDINET:S100VW61
  • ●
    Large shareholderExecutives
    6EDINET
    5.4% of flowShareXTKSEDINET:S100VVZC
  • ●
    Large shareholderExecutives
    6EDINET
    5.8% of flowShareXTKSEDINET:S100QP47
  • ●
    Unknown
    OfficerExecutives
    14EDINET
    33.3% of flowShareXTKSEDINET:S100NYAO
  • ●
    Unknown
    Large shareholderExecutives
    8EDINET
    33.0% of flowShareXTKSEDINET:S100NXTF

12 of 12 declarations

About 株式会社アンビションDXホールディングス

Ambition DX Holdings Co., Ltd. is a Japanese company operating in the health and pharmaceutical sector. It is listed on the XTKS market.